To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

Clinical trial NCT03915769 · COMPLETED

Trial details

NCT number: NCT03915769
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colitis, Ulcerative

Start date: 2019-06-03
Primary completion: 2025-09-30
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.